Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bronchoscopy | 54 | 2023 | 860 | 8.730 |
Why?
|
Lung Neoplasms | 37 | 2023 | 13019 | 2.060 |
Why?
|
Pleural Effusion | 5 | 2017 | 338 | 1.900 |
Why?
|
Airway Obstruction | 10 | 2022 | 663 | 1.800 |
Why?
|
Pulmonary Medicine | 6 | 2022 | 213 | 1.790 |
Why?
|
Pneumothorax | 9 | 2021 | 379 | 1.740 |
Why?
|
Tracheostomy | 6 | 2021 | 400 | 1.700 |
Why?
|
Pleural Effusion, Malignant | 5 | 2019 | 101 | 1.670 |
Why?
|
Pneumonectomy | 8 | 2020 | 1093 | 1.650 |
Why?
|
Multiple Pulmonary Nodules | 3 | 2021 | 153 | 1.510 |
Why?
|
Deoxyribonucleases | 4 | 2021 | 214 | 1.370 |
Why?
|
Endosonography | 8 | 2019 | 610 | 1.370 |
Why?
|
Gastrostomy | 3 | 2021 | 309 | 1.330 |
Why?
|
Pleural Diseases | 3 | 2019 | 139 | 1.320 |
Why?
|
Biopsy | 17 | 2022 | 6756 | 1.250 |
Why?
|
Bronchi | 7 | 2021 | 840 | 1.240 |
Why?
|
Trachea | 10 | 2019 | 1075 | 1.240 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2021 | 265 | 1.120 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 16 | 2023 | 5171 | 1.110 |
Why?
|
Respiratory Aspiration | 2 | 2018 | 81 | 1.050 |
Why?
|
Lung | 14 | 2022 | 9826 | 1.050 |
Why?
|
Tracheal Diseases | 4 | 2016 | 113 | 0.960 |
Why?
|
Pleurodesis | 2 | 2016 | 41 | 0.950 |
Why?
|
Foreign Bodies | 4 | 2018 | 398 | 0.940 |
Why?
|
Device Removal | 5 | 2020 | 652 | 0.890 |
Why?
|
Bronchial Neoplasms | 5 | 2014 | 112 | 0.830 |
Why?
|
Electromagnetic Phenomena | 8 | 2021 | 161 | 0.830 |
Why?
|
Tissue Plasminogen Activator | 3 | 2018 | 1262 | 0.820 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 8 | 2020 | 3038 | 0.820 |
Why?
|
Pulmonary Emphysema | 5 | 2019 | 672 | 0.790 |
Why?
|
Fiducial Markers | 3 | 2019 | 136 | 0.790 |
Why?
|
Stents | 8 | 2019 | 3276 | 0.770 |
Why?
|
Fibrinolytic Agents | 4 | 2021 | 2156 | 0.750 |
Why?
|
Tracheal Stenosis | 3 | 2020 | 226 | 0.740 |
Why?
|
Cryosurgery | 3 | 2022 | 453 | 0.730 |
Why?
|
Thoracic Surgery, Video-Assisted | 3 | 2019 | 273 | 0.730 |
Why?
|
Prosthesis Implantation | 5 | 2019 | 641 | 0.730 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2022 | 384 | 0.710 |
Why?
|
Cryotherapy | 3 | 2018 | 154 | 0.710 |
Why?
|
Argon Plasma Coagulation | 1 | 2019 | 24 | 0.710 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2019 | 57 | 0.700 |
Why?
|
Ventilator Weaning | 1 | 2020 | 148 | 0.690 |
Why?
|
Electrosurgery | 1 | 2019 | 58 | 0.690 |
Why?
|
Intubation, Gastrointestinal | 2 | 2018 | 153 | 0.680 |
Why?
|
Bronchoscopes | 2 | 2018 | 62 | 0.680 |
Why?
|
Hemoptysis | 2 | 2021 | 155 | 0.680 |
Why?
|
Respiratory Tract Fistula | 1 | 2018 | 26 | 0.660 |
Why?
|
Thoracoscopy | 2 | 2017 | 178 | 0.650 |
Why?
|
Drainage | 6 | 2019 | 1140 | 0.640 |
Why?
|
Electromagnetic Fields | 2 | 2019 | 298 | 0.630 |
Why?
|
Pleura | 3 | 2019 | 235 | 0.610 |
Why?
|
Catheter Ablation | 2 | 2022 | 2746 | 0.610 |
Why?
|
Bronchial Diseases | 4 | 2017 | 151 | 0.570 |
Why?
|
Pulmonary Artery | 2 | 2016 | 1911 | 0.560 |
Why?
|
Thoracic Surgical Procedures | 2 | 2017 | 341 | 0.550 |
Why?
|
Endoscopy, Digestive System | 1 | 2018 | 345 | 0.540 |
Why?
|
Blood Loss, Surgical | 1 | 2020 | 656 | 0.530 |
Why?
|
Talc | 1 | 2016 | 47 | 0.530 |
Why?
|
Needles | 1 | 2018 | 448 | 0.530 |
Why?
|
Multicenter Studies as Topic | 2 | 2021 | 1661 | 0.530 |
Why?
|
Prostheses and Implants | 3 | 2020 | 1385 | 0.520 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2015 | 84 | 0.520 |
Why?
|
Thoracic Diseases | 1 | 2016 | 97 | 0.500 |
Why?
|
Chest Tubes | 5 | 2019 | 150 | 0.500 |
Why?
|
Osteochondrodysplasias | 1 | 2016 | 183 | 0.500 |
Why?
|
Surgery, Computer-Assisted | 2 | 2021 | 1009 | 0.470 |
Why?
|
Lung Diseases | 4 | 2018 | 1884 | 0.470 |
Why?
|
Tablets | 1 | 2014 | 147 | 0.470 |
Why?
|
Infection Control | 2 | 2020 | 962 | 0.470 |
Why?
|
Mediastinum | 5 | 2018 | 267 | 0.470 |
Why?
|
Respiratory Tract Diseases | 1 | 2019 | 722 | 0.460 |
Why?
|
Tracheobronchomalacia | 5 | 2016 | 131 | 0.460 |
Why?
|
Humans | 120 | 2023 | 742088 | 0.440 |
Why?
|
Pulmonary Atelectasis | 1 | 2014 | 145 | 0.440 |
Why?
|
Enteral Nutrition | 1 | 2018 | 763 | 0.430 |
Why?
|
Lymph Nodes | 6 | 2019 | 3465 | 0.430 |
Why?
|
Laser Therapy | 1 | 2019 | 1071 | 0.430 |
Why?
|
Mediastinal Neoplasms | 3 | 2019 | 421 | 0.420 |
Why?
|
Iatrogenic Disease | 1 | 2015 | 545 | 0.410 |
Why?
|
Manometry | 1 | 2013 | 444 | 0.390 |
Why?
|
Biopsy, Fine-Needle | 2 | 2013 | 1093 | 0.390 |
Why?
|
Ultrasonography | 3 | 2018 | 5978 | 0.370 |
Why?
|
Radiosurgery | 2 | 2019 | 1309 | 0.360 |
Why?
|
Professional Competence | 1 | 2013 | 448 | 0.350 |
Why?
|
Aged | 41 | 2021 | 162944 | 0.330 |
Why?
|
Empyema, Pleural | 2 | 2021 | 62 | 0.330 |
Why?
|
Respiratory Insufficiency | 4 | 2019 | 1199 | 0.310 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2566 | 0.310 |
Why?
|
Heart Atria | 1 | 2013 | 1348 | 0.300 |
Why?
|
Bezoars | 1 | 2007 | 30 | 0.300 |
Why?
|
Feasibility Studies | 4 | 2018 | 5062 | 0.300 |
Why?
|
Severity of Illness Index | 8 | 2020 | 15530 | 0.290 |
Why?
|
Male | 51 | 2021 | 349538 | 0.290 |
Why?
|
Pulmonary Embolism | 2 | 2022 | 2370 | 0.290 |
Why?
|
Intubation, Intratracheal | 2 | 2014 | 1357 | 0.290 |
Why?
|
Hemorrhage | 2 | 2016 | 3461 | 0.290 |
Why?
|
Female | 51 | 2021 | 379592 | 0.280 |
Why?
|
Aged, 80 and over | 22 | 2021 | 57683 | 0.270 |
Why?
|
Middle Aged | 41 | 2021 | 213127 | 0.270 |
Why?
|
Prospective Studies | 16 | 2021 | 53187 | 0.260 |
Why?
|
Lung Transplantation | 3 | 2017 | 1155 | 0.260 |
Why?
|
Dexmedetomidine | 1 | 2009 | 315 | 0.260 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3507 | 0.250 |
Why?
|
Neoplasm Staging | 10 | 2017 | 11001 | 0.240 |
Why?
|
Robotics | 2 | 2022 | 892 | 0.240 |
Why?
|
Sensitivity and Specificity | 10 | 2021 | 14720 | 0.240 |
Why?
|
Receptor Protein-Tyrosine Kinases | 4 | 2016 | 1659 | 0.240 |
Why?
|
Patient Selection | 1 | 2016 | 4214 | 0.230 |
Why?
|
Tomography, X-Ray Computed | 13 | 2021 | 20086 | 0.230 |
Why?
|
Pandemics | 2 | 2020 | 8328 | 0.230 |
Why?
|
Retrospective Studies | 19 | 2023 | 77098 | 0.220 |
Why?
|
Adult | 33 | 2021 | 213712 | 0.220 |
Why?
|
Stomach | 1 | 2007 | 697 | 0.220 |
Why?
|
Postoperative Complications | 8 | 2019 | 15244 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
Carotid Stenosis | 1 | 2009 | 854 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.210 |
Why?
|
Pharmacy | 1 | 2023 | 91 | 0.200 |
Why?
|
Hypnotics and Sedatives | 1 | 2009 | 1158 | 0.200 |
Why?
|
Communicable Diseases | 2 | 2015 | 878 | 0.200 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2015 | 325 | 0.190 |
Why?
|
Microwaves | 1 | 2022 | 191 | 0.190 |
Why?
|
Histoplasma | 1 | 2020 | 41 | 0.180 |
Why?
|
Papilloma | 1 | 2021 | 148 | 0.180 |
Why?
|
Thinking | 1 | 2003 | 319 | 0.180 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2016 | 9941 | 0.180 |
Why?
|
Hemostatic Techniques | 1 | 2021 | 116 | 0.180 |
Why?
|
Histoplasmosis | 1 | 2020 | 66 | 0.180 |
Why?
|
Surgical Instruments | 2 | 2019 | 394 | 0.180 |
Why?
|
Lung Diseases, Fungal | 1 | 2020 | 122 | 0.170 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2020 | 111 | 0.170 |
Why?
|
Models, Economic | 1 | 2003 | 713 | 0.170 |
Why?
|
Thoracostomy | 2 | 2016 | 72 | 0.170 |
Why?
|
Electrocoagulation | 1 | 2019 | 158 | 0.170 |
Why?
|
Nurse's Role | 1 | 2020 | 209 | 0.170 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2021 | 766 | 0.170 |
Why?
|
Tracheomalacia | 2 | 2016 | 63 | 0.160 |
Why?
|
Nasopharynx | 1 | 2021 | 379 | 0.160 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2018 | 87 | 0.160 |
Why?
|
ras Proteins | 2 | 2013 | 1060 | 0.160 |
Why?
|
Oropharynx | 1 | 2018 | 127 | 0.160 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2013 | 4029 | 0.150 |
Why?
|
Diagnosis, Differential | 8 | 2017 | 12958 | 0.150 |
Why?
|
Carrier State | 1 | 2021 | 518 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.150 |
Why?
|
Esophageal Stenosis | 1 | 2018 | 194 | 0.150 |
Why?
|
Parasitic Diseases | 2 | 2007 | 75 | 0.150 |
Why?
|
Delphi Technique | 1 | 2020 | 778 | 0.150 |
Why?
|
Adenocarcinoma | 2 | 2016 | 6347 | 0.150 |
Why?
|
Coloring Agents | 1 | 2019 | 565 | 0.140 |
Why?
|
Pilot Projects | 3 | 2022 | 8297 | 0.140 |
Why?
|
Tracheotomy | 2 | 2020 | 166 | 0.140 |
Why?
|
Risk Adjustment | 1 | 2020 | 594 | 0.140 |
Why?
|
Debridement | 2 | 2016 | 492 | 0.140 |
Why?
|
Respiratory System | 1 | 2019 | 555 | 0.140 |
Why?
|
Prosthesis Design | 3 | 2019 | 2110 | 0.130 |
Why?
|
Models, Anatomic | 1 | 2019 | 690 | 0.130 |
Why?
|
Silicones | 2 | 2016 | 248 | 0.130 |
Why?
|
Heart Failure | 3 | 2016 | 10856 | 0.130 |
Why?
|
Equipment Design | 2 | 2021 | 3582 | 0.130 |
Why?
|
Mediastinal Diseases | 1 | 2015 | 89 | 0.130 |
Why?
|
Quality of Life | 2 | 2016 | 12730 | 0.130 |
Why?
|
Bronchoalveolar Lavage | 2 | 2021 | 120 | 0.130 |
Why?
|
Treatment Outcome | 10 | 2020 | 62966 | 0.120 |
Why?
|
Steroids | 1 | 2020 | 931 | 0.120 |
Why?
|
United States | 9 | 2021 | 69693 | 0.120 |
Why?
|
Enchondromatosis | 1 | 2014 | 14 | 0.120 |
Why?
|
Chondroma | 1 | 2014 | 58 | 0.120 |
Why?
|
Surgical Wound Dehiscence | 1 | 2015 | 215 | 0.120 |
Why?
|
Lymphatic Metastasis | 3 | 2019 | 2906 | 0.120 |
Why?
|
Capnography | 1 | 2014 | 89 | 0.120 |
Why?
|
Accreditation | 1 | 2017 | 449 | 0.120 |
Why?
|
Lymphatic Diseases | 1 | 2015 | 324 | 0.120 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 474 | 0.120 |
Why?
|
Tracheitis | 1 | 2013 | 28 | 0.120 |
Why?
|
Respiratory Tract Infections | 1 | 2021 | 959 | 0.120 |
Why?
|
Carbon Dioxide | 1 | 2018 | 1141 | 0.120 |
Why?
|
Corynebacterium | 1 | 2013 | 47 | 0.110 |
Why?
|
Corynebacterium Infections | 1 | 2013 | 27 | 0.110 |
Why?
|
Tranexamic Acid | 1 | 2015 | 146 | 0.110 |
Why?
|
Pulmonary Edema | 1 | 2016 | 415 | 0.110 |
Why?
|
Airway Management | 1 | 2016 | 324 | 0.110 |
Why?
|
Sodium Chloride | 1 | 2015 | 625 | 0.110 |
Why?
|
Capsules | 1 | 2013 | 199 | 0.110 |
Why?
|
Education, Medical, Graduate | 2 | 2017 | 2283 | 0.110 |
Why?
|
Foreign-Body Reaction | 1 | 2013 | 157 | 0.110 |
Why?
|
Physician's Role | 1 | 2019 | 942 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 2 | 2016 | 4029 | 0.100 |
Why?
|
Plasmacytoma | 1 | 2013 | 182 | 0.100 |
Why?
|
Radiography, Thoracic | 1 | 2018 | 1265 | 0.100 |
Why?
|
Epinephrine | 1 | 2015 | 793 | 0.100 |
Why?
|
Vasoconstrictor Agents | 1 | 2015 | 643 | 0.100 |
Why?
|
Consensus | 1 | 2021 | 2935 | 0.100 |
Why?
|
Ablation Techniques | 1 | 2014 | 249 | 0.100 |
Why?
|
Sjogren's Syndrome | 1 | 2013 | 229 | 0.100 |
Why?
|
Chondrosarcoma | 1 | 2014 | 309 | 0.100 |
Why?
|
Polypharmacy | 1 | 2014 | 294 | 0.100 |
Why?
|
Program Evaluation | 1 | 2020 | 2485 | 0.100 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39004 | 0.100 |
Why?
|
Prognosis | 3 | 2018 | 29010 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 2 | 2013 | 4553 | 0.100 |
Why?
|
Fellowships and Scholarships | 2 | 2017 | 1066 | 0.100 |
Why?
|
Developing Countries | 1 | 2003 | 2789 | 0.100 |
Why?
|
Gene Rearrangement | 1 | 2016 | 1179 | 0.090 |
Why?
|
Lymphoma | 1 | 2019 | 1873 | 0.090 |
Why?
|
Recurrence | 3 | 2019 | 8333 | 0.090 |
Why?
|
Lung Diseases, Interstitial | 1 | 2018 | 807 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2020 | 19862 | 0.090 |
Why?
|
Critical Care | 2 | 2020 | 2640 | 0.090 |
Why?
|
Ticlopidine | 1 | 2015 | 899 | 0.090 |
Why?
|
Certification | 1 | 2013 | 423 | 0.090 |
Why?
|
Catheters, Indwelling | 1 | 2012 | 425 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 1683 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1585 | 0.090 |
Why?
|
Comorbidity | 4 | 2019 | 10372 | 0.090 |
Why?
|
Radiology | 1 | 2023 | 2090 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 2 | 2016 | 3123 | 0.080 |
Why?
|
Radiography | 3 | 2015 | 7010 | 0.080 |
Why?
|
Oxygen Consumption | 1 | 2015 | 1869 | 0.080 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 1613 | 0.080 |
Why?
|
Deglutition Disorders | 1 | 2014 | 604 | 0.080 |
Why?
|
Cohort Studies | 3 | 2021 | 40450 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4839 | 0.080 |
Why?
|
Lung Diseases, Parasitic | 1 | 2007 | 14 | 0.080 |
Why?
|
Trichinellosis | 1 | 2007 | 36 | 0.080 |
Why?
|
Protozoan Infections | 1 | 2007 | 39 | 0.080 |
Why?
|
Suture Techniques | 1 | 2012 | 797 | 0.070 |
Why?
|
Amyloidosis | 1 | 2013 | 795 | 0.070 |
Why?
|
Educational Measurement | 1 | 2013 | 1206 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3839 | 0.070 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3612 | 0.070 |
Why?
|
Gastroparesis | 1 | 2007 | 131 | 0.060 |
Why?
|
Teaching | 1 | 2013 | 1174 | 0.060 |
Why?
|
Disease Management | 1 | 2016 | 2450 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2018 | 3679 | 0.060 |
Why?
|
Cardiomyopathies | 2 | 2007 | 1912 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2410 | 0.060 |
Why?
|
Young Adult | 7 | 2021 | 56350 | 0.060 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2008 | 274 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8621 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2014 | 1864 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6171 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15056 | 0.060 |
Why?
|
Maxillary Diseases | 1 | 2003 | 51 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3070 | 0.060 |
Why?
|
Risk Factors | 5 | 2018 | 72145 | 0.060 |
Why?
|
Curriculum | 1 | 2017 | 3589 | 0.060 |
Why?
|
Length of Stay | 1 | 2017 | 6294 | 0.060 |
Why?
|
Mutation | 4 | 2016 | 29717 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2016 | 5163 | 0.060 |
Why?
|
Dysautonomia, Familial | 1 | 2003 | 95 | 0.050 |
Why?
|
Neoplasms | 2 | 2023 | 21596 | 0.050 |
Why?
|
Pericardium | 1 | 2007 | 667 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 3067 | 0.050 |
Why?
|
Oxygen | 1 | 2014 | 4169 | 0.050 |
Why?
|
Genotype | 2 | 2014 | 12946 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2274 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2014 | 2211 | 0.050 |
Why?
|
Lymphocytosis | 1 | 2002 | 119 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5462 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 5385 | 0.050 |
Why?
|
Constriction, Pathologic | 2 | 2015 | 1095 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5662 | 0.050 |
Why?
|
Fatal Outcome | 2 | 2015 | 1849 | 0.040 |
Why?
|
Residual Volume | 1 | 2019 | 41 | 0.040 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2023 | 448 | 0.040 |
Why?
|
Osteomyelitis | 1 | 2003 | 402 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2014 | 4249 | 0.040 |
Why?
|
Endoscopy | 1 | 2007 | 1774 | 0.040 |
Why?
|
Granulation Tissue | 1 | 2017 | 93 | 0.040 |
Why?
|
Chagas Cardiomyopathy | 2 | 2007 | 72 | 0.040 |
Why?
|
Medical Illustration | 1 | 2017 | 133 | 0.040 |
Why?
|
Smoking | 1 | 2013 | 8969 | 0.030 |
Why?
|
Polypropylenes | 1 | 2016 | 63 | 0.030 |
Why?
|
Asthma | 1 | 2014 | 5955 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2013 | 5133 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2012 | 4229 | 0.030 |
Why?
|
Schizophrenia | 1 | 2014 | 6874 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2018 | 1104 | 0.030 |
Why?
|
Staphylococcal Infections | 1 | 2003 | 1398 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 6534 | 0.030 |
Why?
|
Computer-Aided Design | 1 | 2016 | 298 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2019 | 1741 | 0.030 |
Why?
|
Chile | 1 | 2014 | 237 | 0.030 |
Why?
|
Heart Diseases | 1 | 2007 | 2789 | 0.030 |
Why?
|
Heart | 1 | 2007 | 4462 | 0.030 |
Why?
|
Fistula | 1 | 2015 | 218 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2018 | 602 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2015 | 8829 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11363 | 0.030 |
Why?
|
Etoposide | 1 | 2015 | 637 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2014 | 11690 | 0.030 |
Why?
|
Drug Combinations | 1 | 2018 | 1961 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2020 | 1548 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9185 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 3913 | 0.030 |
Why?
|
Preoperative Care | 1 | 2021 | 2245 | 0.030 |
Why?
|
Carboplatin | 1 | 2015 | 799 | 0.030 |
Why?
|
Poverty | 1 | 2003 | 2646 | 0.020 |
Why?
|
Hospitals, University | 1 | 2013 | 571 | 0.020 |
Why?
|
Child, Preschool | 1 | 2014 | 40955 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2015 | 770 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3339 | 0.020 |
Why?
|
Time Factors | 3 | 2017 | 40054 | 0.020 |
Why?
|
Waiting Lists | 1 | 2014 | 692 | 0.020 |
Why?
|
Tumor Burden | 1 | 2016 | 1905 | 0.020 |
Why?
|
Spirometry | 1 | 2013 | 862 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2015 | 877 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4929 | 0.020 |
Why?
|
Cough | 1 | 2013 | 555 | 0.020 |
Why?
|
Equipment Failure | 1 | 2012 | 579 | 0.020 |
Why?
|
Clinical Competence | 2 | 2017 | 4681 | 0.020 |
Why?
|
Incidental Findings | 1 | 2014 | 688 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2014 | 1640 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2885 | 0.020 |
Why?
|
Necrosis | 1 | 2013 | 1643 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2002 | 4438 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9679 | 0.020 |
Why?
|
Faculty, Medical | 1 | 2017 | 1182 | 0.020 |
Why?
|
Specialization | 1 | 2013 | 777 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2016 | 1581 | 0.020 |
Why?
|
Disease Progression | 2 | 2015 | 13256 | 0.020 |
Why?
|
Exercise Test | 1 | 2015 | 2075 | 0.020 |
Why?
|
Filariasis | 1 | 2007 | 28 | 0.020 |
Why?
|
Echinococcosis | 1 | 2007 | 30 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 2638 | 0.020 |
Why?
|
Amebiasis | 1 | 2007 | 34 | 0.020 |
Why?
|
Trypanosomiasis, African | 1 | 2007 | 28 | 0.020 |
Why?
|
Endomyocardial Fibrosis | 1 | 2007 | 41 | 0.020 |
Why?
|
Oncogenes | 1 | 2013 | 1263 | 0.020 |
Why?
|
Cysticercosis | 1 | 2007 | 34 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3585 | 0.020 |
Why?
|
Schistosomiasis | 1 | 2007 | 62 | 0.020 |
Why?
|
Toxoplasmosis | 1 | 2007 | 91 | 0.020 |
Why?
|
Pulmonary Eosinophilia | 1 | 2007 | 82 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3528 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3587 | 0.020 |
Why?
|
Zoonoses | 1 | 2007 | 184 | 0.020 |
Why?
|
Pericarditis | 1 | 2007 | 128 | 0.020 |
Why?
|
Hospitalization | 1 | 2005 | 10232 | 0.020 |
Why?
|
Pyrazoles | 1 | 2016 | 1970 | 0.020 |
Why?
|
Acute Disease | 1 | 2016 | 7141 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5238 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3740 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4187 | 0.020 |
Why?
|
Pyridines | 1 | 2016 | 2818 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.010 |
Why?
|
Liver Transplantation | 1 | 2014 | 2117 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9305 | 0.010 |
Why?
|
Adolescent | 3 | 2019 | 85649 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3548 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7716 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12344 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5522 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16665 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2003 | 2027 | 0.010 |
Why?
|
Hypertension, Pulmonary | 1 | 2007 | 1527 | 0.010 |
Why?
|
HIV Infections | 1 | 2002 | 16678 | 0.010 |
Why?
|
Health Surveys | 1 | 2005 | 4030 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 2145 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 23320 | 0.010 |
Why?
|
Pneumonia | 1 | 2005 | 2117 | 0.010 |
Why?
|
Patient Discharge | 1 | 2005 | 3300 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13655 | 0.010 |
Why?
|
Animals | 2 | 2007 | 168561 | 0.000 |
Why?
|